JP2022541265A5 - - Google Patents

Info

Publication number
JP2022541265A5
JP2022541265A5 JP2022502994A JP2022502994A JP2022541265A5 JP 2022541265 A5 JP2022541265 A5 JP 2022541265A5 JP 2022502994 A JP2022502994 A JP 2022502994A JP 2022502994 A JP2022502994 A JP 2022502994A JP 2022541265 A5 JP2022541265 A5 JP 2022541265A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
pyrazolo
pyrrolo
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022502994A
Other languages
English (en)
Japanese (ja)
Other versions
JP7620611B2 (ja
JP2022541265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042252 external-priority patent/WO2021011727A1/en
Publication of JP2022541265A publication Critical patent/JP2022541265A/ja
Publication of JP2022541265A5 publication Critical patent/JP2022541265A5/ja
Application granted granted Critical
Publication of JP7620611B2 publication Critical patent/JP7620611B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022502994A 2019-07-18 2020-07-16 ＩＲＡＫ４阻害剤として有用なピラゾロ［３，４－ｄ］ピロロ［１，２－ｂ］ピリダジニル化合物 Active JP7620611B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962875567P 2019-07-18 2019-07-18
US62/875,567 2019-07-18
PCT/US2020/042252 WO2021011727A1 (en) 2019-07-18 2020-07-16 PYRAZOLO[3,4-d]PYRROLO[1,2-b]PYRIDAZINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS

Publications (3)

Publication Number Publication Date
JP2022541265A JP2022541265A (ja) 2022-09-22
JP2022541265A5 true JP2022541265A5 (https=) 2023-07-11
JP7620611B2 JP7620611B2 (ja) 2025-01-23

Family

ID=71995095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502994A Active JP7620611B2 (ja) 2019-07-18 2020-07-16 ＩＲＡＫ４阻害剤として有用なピラゾロ［３，４－ｄ］ピロロ［１，２－ｂ］ピリダジニル化合物

Country Status (6)

Country Link
US (1) US12304914B2 (https=)
EP (1) EP3999512B1 (https=)
JP (1) JP7620611B2 (https=)
CN (1) CN114127075B (https=)
ES (1) ES2960521T3 (https=)
WO (1) WO2021011727A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023205463A1 (en) 2022-04-22 2023-10-26 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2024104968A1 (en) * 2022-11-14 2024-05-23 Actelion Pharmaceuticals Ltd Pyrazolopyrrolopyridazines and their uses as pdgfr inhibitors

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450769A1 (en) 2001-06-15 2002-12-27 Vertex Pharmaceuticals Incorporated 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
AUPR688101A0 (en) 2001-08-08 2001-08-30 Luminis Pty Limited Protein domains and their ligands
GB0211019D0 (en) 2002-05-14 2002-06-26 Syngenta Ltd Novel compounds
EP1518855B1 (en) 2002-06-28 2011-10-26 Astellas Pharma Inc. Diaminopyrimidinecarboxa mide derivative
MXPA05007503A (es) 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
WO2005007646A1 (en) 2003-07-10 2005-01-27 Neurogen Corporation Substituted heterocyclic diarylamine analogues
GB0402653D0 (en) 2004-02-06 2004-03-10 Cyclacel Ltd Compounds
US7521457B2 (en) 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
FR2896503B1 (fr) 2006-01-23 2012-07-13 Aventis Pharma Sa Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
KR20100020454A (ko) 2007-06-08 2010-02-22 바이엘 크롭사이언스 소시에떼아노님 살진균제 헤테로사이클릴-피리미디닐-아미노 유도체
WO2009046416A1 (en) 2007-10-05 2009-04-09 Targegen Inc. Anilinopyrimidines as jak kinase inhibitors
EP2361902A4 (en) 2008-11-21 2012-04-25 Astellas Pharma Inc 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
WO2010061971A1 (ja) 2008-11-28 2010-06-03 興和株式会社 ピリジン－３－カルボキシアミド誘導体
EP2440204B1 (en) 2009-06-12 2013-12-18 Bristol-Myers Squibb Company Nicotinamide compounds useful as kinase modulators
TW201107330A (en) 2009-07-31 2011-03-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
EP2493863B1 (en) 2009-10-30 2015-02-25 Janssen Pharmaceutica NV Phenoxy-substituted pyrimidines as opioid receptor modulators
PH12012501000A1 (en) 2009-12-01 2013-02-11 Abbvie Inc Novel tricyclic compounds
KR20120130104A (ko) 2010-02-01 2012-11-28 닛뽕 케미파 가부시키가이샤 Ｇｐｒ119 작동약
AR085435A1 (es) 2011-03-17 2013-10-02 Bristol Myers Squibb Co Inhibidores de pirrolopiridazina jak3 y su uso para el tratamiento de enfermedades inflamatorias y autoinmunes
JP2014515029A (ja) 2011-04-29 2014-06-26 アイカーン・スクール・オブ・メディシン・アト・マウント・シナイ キナーゼ阻害剤
ES2575604T3 (es) 2012-01-13 2016-06-29 Bristol-Myers Squibb Company Compuestos de piridilo sustituidos con tiazolilo o tiadiazolilo útiles como inhibidores cinasa
CN104169275B (zh) 2012-01-13 2017-06-09 百时美施贵宝公司 用作激酶抑制剂的三唑取代的吡啶化合物
EP2802576B1 (en) 2012-01-13 2018-06-27 Bristol-Myers Squibb Company Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
BR112015009850A2 (pt) 2012-11-08 2017-07-11 Bristol Myers Squibb Co compostos de piridila substituídos por heteroarila úteis como moduladores de quinase
KR102233252B1 (ko) 2012-11-08 2021-03-26 브리스톨-마이어스 스큅 컴퍼니 ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
JP6215338B2 (ja) 2012-11-08 2017-10-18 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ キナーゼモジュレーターとして有用な二環式ヘテロ環置換ピリジル化合物
TWI582077B (zh) 2013-11-07 2017-05-11 必治妥美雅史谷比公司 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
LT3466955T (lt) 2014-01-13 2021-02-25 Aurigene Discovery Technologies Limited Oksazol[4,5-b]piridino ir tiazol[4,5-b]piridino darinių, kaip irak4 inhibitorių, skirtų vėžio gydymui, gamybos būdas
DK3126330T3 (en) 2014-04-04 2019-04-23 Pfizer BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS
AU2015275730A1 (en) 2014-06-20 2016-12-15 Aurigene Discovery Technologies Limited Substituted indazole compounds as IRAK4 inhibitors
WO2016144849A1 (en) 2015-03-12 2016-09-15 Merck Sharp & Dohme Corp. Thienopyrazine inhibitors of irak4 activity
US10155765B2 (en) 2015-03-12 2018-12-18 Merck Sharp & Dohme Corp. Carboxamide inhibitors of IRAK4 activity
ES2822956T3 (es) * 2015-06-24 2021-05-05 Bristol Myers Squibb Co Compuestos de aminopiridina sustituidos con heteroarilo
EP3313840B1 (en) 2015-06-24 2019-07-24 Bristol-Myers Squibb Company Heteroaryl substituted aminopyridine compounds
WO2017025849A1 (en) 2015-08-13 2017-02-16 Pfizer Inc. Bicyclic-fused heteroaryl or aryl compounds
HUE053705T2 (hu) 2015-08-27 2021-07-28 Pfizer Biciklusos kondenzált heteroaril- vagy aril- vegyületek IRAK4 modulátorokként
SG10202011653WA (en) * 2016-06-01 2020-12-30 Bayer Pharma AG Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases
PT3621960T (pt) 2017-05-11 2021-09-16 Bristol Myers Squibb Co Tienopiridinas e benzotiofenos úteis como inibidores de irak4
CN107652293A (zh) * 2017-09-26 2018-02-02 中国药科大学 咪唑并哒嗪类irak4抑制剂及其制备方法和应用

Similar Documents

Publication Publication Date Title
KR101312736B1 (ko) 피라졸로피리딘 유도체
JP7084961B2 (ja) キナーゼ阻害剤としてのピラゾロピリミジン誘導体
TWI644671B (zh) Ｐ２ｘ７調節劑
JP6924267B2 (ja) ピロロ［１，２−ｂ］ピリダジン誘導体
JP2022545364A5 (https=)
TWI911262B (zh) 化合物、組合物及方法
IL295461A (en) Imidazopyrrolopyridine as inhibitors of the jak family of kinases
RU2014106020A (ru) Ингибиторы втк
JP2022541265A5 (https=)
JP2014516074A5 (https=)
CN118234730A (zh) 杂环nlrp3抑制剂
ES2749679T3 (es) Compuestos de pirrolotriazina amina sustituidos como inhibidores de PI3k
JP2018524331A5 (https=)
US20150266856A1 (en) RORGamma Modulators
JP2009506006A (ja) ｐ３８ＭＡＰキナーゼ阻害剤およびその使用方法
CN103764653A (zh) 作为c-Kit激酶抑制剂的化合物和组合物
JP2019512534A (ja) Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体
EP4522612A1 (en) Tyk2 inhibitors
JP2003526601A5 (https=)
CN115667259A (zh) 抑制h-pgds的稠环化合物
JP2023513488A5 (https=)
TW202513565A (zh) Prmt5抑制劑及其用途
CN119866338A (zh) 酪氨酸激酶2抑制剂及其用途
US20240308980A1 (en) Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
CA3080123C (en) Btk inhibitor compounds